New horizons in pharmaceutical regulation

被引:8
|
作者
Breckenridge, Alasdair [1 ]
Mello, Michelle [2 ]
Psaty, Bruce M. [3 ]
机构
[1] Med & Healthcare Prod Regulatory Agcy, London SW1W 9SZ, England
[2] Harvard Univ, Cambridge, MA 02115 USA
[3] Univ Washington, Med Epidemiol & Hlth Serv, Seattle, WA 98101 USA
关键词
D O I
10.1038/nrd3787
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A life cycle approach to pharmaceutical regulation, in which the benefit–risk balance of new drugs continues to be robustly assessed following market approval, is emerging in both the United States and Europe.
引用
收藏
页码:501 / 502
页数:2
相关论文
共 50 条
  • [21] New Horizons
    不详
    ARTNEWS, 2021, 120 (03): : 12 - 12
  • [22] New Horizons
    Goldmann, A. J.
    OPERA NEWS, 2018, 83 (05): : 14 - 15
  • [23] New Horizons
    Arthur M. Michalek
    Journal of Cancer Education, 2018, 33 : 1 - 1
  • [24] New Horizons
    Steiner, Dora
    LIBRARY JOURNAL, 1951, 76 (20) : 1874 - +
  • [25] New horizons
    Mosher, AD
    MODERN LANGUAGE JOURNAL, 2001, 85 (03): : 485 - 486
  • [26] New Horizons
    McKenzie, Fiona
    Craighead, Harold
    NANOSCALE HORIZONS, 2016, 1 (01) : 8 - 10
  • [27] New horizons
    Pierce, Julia
    Engineer, 2015, 296 (7859) : 44 - 45
  • [28] NEW HORIZONS
    Rangel, Flaminio de Oliveira
    PROMETEICA-REVISTA DE FILOSOFIA Y CIENCIAS, 2019, (18): : 5 - 5
  • [29] NEW HORIZONS
    PETERSEN, TS
    AAPG BULLETIN-AMERICAN ASSOCIATION OF PETROLEUM GEOLOGISTS, 1954, 38 (07): : 1388 - 1395
  • [30] To New Horizons
    Drake, Cathryn
    ARTFORUM INTERNATIONAL, 2018, 56 (10): : 327 - 327